Skip to main content
SpringerLink
Log in

Teratogens inducing congenital abdominal wall defects in animal models

  • Review Article
  • Published:
Pediatric Surgery International Aims and scope Submit manuscript

Abstract

Congenital abdominal wall defects are common anomalies which include gastroschisis, omphalocele and umbilical cord hernia. Recent reports indicate that gastroschisis is increasing in prevalence, whereas omphalocele has remained steady, suggesting that environmental factors may play a part in their pathogenesis. The aim of this study is to review animal teratogen studies resulting in abdominal wall defects to investigate their possible causes. Each report was examined not only for the teratogens causing the defects, but also to carefully identify the defect occurring and its correlation with the known clinical anomalies. We found many discrepancies between the nomenclature used by animal teratology investigators and that used by clinicians. We were able to confirm the induction of gastroschisis by 22 teratogens, omphalocele by 9 teratogens and umbilical cord hernia by 8. There is no doubt that environmental factors may be responsible, at least in part, for all three of the clinical abdominal wall defects. Future studies should take care to appreciate the differences between these anomalies and describe them in detail, so that accurate and meaningful conclusions can be obtained.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Klein MD (2006) Congenital defects of the abdominal wall. In: Grosfeld JL, O’Neill JA, Coran AG, Fonkalsrud EW (eds) Pediatric surgery. Elsevier, Philadelphia, pp 1157–1171

    Google Scholar 

  2. Drewett M, Michailidis GD, Burge D (2006) The perinatal management of gastroschisis. Early Hum Dev 82:305–312

    PubMed  Google Scholar 

  3. Snyder CL (1999) Outcome analysis for gastroschisis. J Pediatr Surg 34:1253–1256

    CAS  PubMed  Google Scholar 

  4. Axt R, Quijano F, Boos R, Hendrik HJ, Jessberger HJ, Schwaiger C, Schmidt W (1999) Omphalocele and gastroschisis: prenatal diagnosis and peripartal management. A case analysis of the years 1989–1997 at the Department of Obstetrics and Gynecology, University of Homburg/Saar. Eur J Obstet Gynecol Reprod Biol 87:47–54

    CAS  PubMed  Google Scholar 

  5. Hunter AG, Stevenson RE (2008) Gastroschisis: clinical presentation and associations. Am J Med Genet C Semin Med Genet 148C:219–230

    PubMed  Google Scholar 

  6. Mastroiacovo P, Lisi A, Castilla EE, Martinez-Frias ML, Bermejo E, Marengo L, Kucik J, Siffel C, Halliday J, Gatt M, Anneren G, Bianchi F, Canessa MA, Danderfer R, de Walle H, Harris J, Li Z, Lowry RB, McDonell R, Merlob P, Metneki J, Mutchinick O, Robert-Gnansia E, Scarano G, Sipek A, Potzsch S, Szabova E, Yevtushok L (2007) Gastroschisis and associated defects: an international study. Am J Med Genet A 143:660–671

    PubMed  Google Scholar 

  7. NBDPN (2007) Population-based birth defects surveillance data from selected states, 2000–2004. Birth Defects Res A Clin Mol Teratol 79:874–942

    Google Scholar 

  8. Hwang PJ, Kousseff BG (2004) Omphalocele and gastroschisis: an 18-year review study. Genet Med 6:232–236

    PubMed  Google Scholar 

  9. Stoll C, Alembik Y, Dott B, Roth MP (2001) Risk factors in congenital abdominal wall defects (omphalocele and gastroschisi): a study in a series of 265, 858 consecutive births. Ann Genet 44:201–208

    CAS  PubMed  Google Scholar 

  10. Stoll C, Alembik Y, Dott B, Roth MP (2008) Omphalocele and gastroschisis and associated malformations. Am J Med Genet A 146A:1280–1285

    PubMed  Google Scholar 

  11. Rankin J, Dillon E, Wright C (1999) Congenital anterior abdominal wall defects in the north of England, 1986–1996: occurrence and outcome. Prenat Diagn 19:662–668

    CAS  PubMed  Google Scholar 

  12. Boyd PA, Bhattacharjee A, Gould S, Manning N, Chamberlain P (1998) Outcome of prenatally diagnosed anterior abdominal wall defects. Arch Dis Child Fetal Neonatal Ed 78:F209–F213

    CAS  PubMed  Google Scholar 

  13. Calzolari E, Volpato S, Bianchi F, Cianciulli D, Tenconi R, Clementi M, Calabro A, Lungarotti S, Mastroiacovo PP, Botto L et al (1993) Omphalocele and gastroschisis: a collaborative study of five Italian congenital malformation registries. Teratology 47:47–55

    CAS  PubMed  Google Scholar 

  14. Lindham S (1981) Omphalocele and gastroschisis in Sweden 1965–1976. Acta Paediatr Scand 70:55–60

    CAS  PubMed  Google Scholar 

  15. Kazaura MR, Lie RT, Irgens LM, Didriksen A, Kapstad M, Egenaes J, Bjerkedal T (2004) Increasing risk of gastroschisis in Norway: an age-period-cohort analysis. Am J Epidemiol 159:358–363

    PubMed  Google Scholar 

  16. Di Tanna GL, Rosano A, Mastroiacovo P (2002) Prevalence of gastroschisis at birth: retrospective study. BMJ 325:1389–1390

    PubMed  Google Scholar 

  17. Suita S, Okamatsu T, Yamamoto T, Handa N, Nirasawa Y, Watanabe Y, Yanagihara J, Nishijima E, Hirobe S, Nio M, Gomi A, Horisawa M (2000) Changing profile of abdominal wall defects in Japan: results of a national survey. J Pediatr Surg 35:66–71 (discussion 72)

    CAS  PubMed  Google Scholar 

  18. Benson CD, Penberthy GC, Hill EJ (1949) Hernia into umbilical cord and omphalocele. Arch Surg 58:833–847

    CAS  PubMed  Google Scholar 

  19. Moore TC, Stokes GE (1953) Gastroschisis; report of two cases treated by a modification of the gross operation for omphalocele. Surgery 33:112–120

    CAS  PubMed  Google Scholar 

  20. http://www.who.int/classifications/apps/icd/icd10online/

  21. Padmanabhan R, al-Zuhair AG (1987) Congenital malformations and intrauterine growth retardation in streptozotocin induced diabetes during gestation in the rat. Reprod Toxicol 1:117–125

    PubMed  Google Scholar 

  22. Samarawickrama GP, Webb M (1981) The acute toxicity and teratogenicity of cadmium in the pregnant rat. J Appl Toxicol 1:264–269

    CAS  PubMed  Google Scholar 

  23. Beauchemin RR Jr, Gartner LP, Provenza DV (1984) Alcohol induced cardiac malformations in the rat. Anat Anz 155:17–28

    CAS  PubMed  Google Scholar 

  24. Fisher CJ, Sawyer RH (1980) The effect of triamcinolone on the development of the bursa of fabricius in chick embryos. Teratology 22:7–12

    CAS  PubMed  Google Scholar 

  25. Gutova M, Elis J, Raskova H (1971) Teratogenic effect of 6-azauridine in rats. Teratology 4:287–294

    CAS  PubMed  Google Scholar 

  26. Padmanabhan R (1998) Retinoic acid-induced caudal regression syndrome in the mouse fetus. Reprod Toxicol 12:139–151

    CAS  PubMed  Google Scholar 

  27. Sukra Y, Sastrohadinoto S, Budiarso IT (1976) Effect of selenium and mercury on gross morphology and histopathology of chick embryos. Poult Sci 55:2424–2433

    CAS  PubMed  Google Scholar 

  28. Szabo KT, DiFebbo ME, Phelan DG (1978) The effects of gold-containing compounds on pregnant rabbits and their fetuses. Vet Pathol 15(Suppl 5):97–102

    CAS  PubMed  Google Scholar 

  29. Ferm VH (1971) Developmental malformations induced by cadmium. A study of timed injections during embryogenesis. Biol Neonate 19:101–107

    CAS  PubMed  Google Scholar 

  30. Singh J (2003) Gastroschisis is caused by the combination of carbon monoxide and protein–zinc deficiencies in mice. Birth Defects Res B Dev Reprod Toxicol 68:355–362

    CAS  PubMed  Google Scholar 

  31. Pampfer S, Streffer C (1988) Prenatal death and malformations after irradiation of mouse zygotes with neutrons or X-rays. Teratology 37:599–607

    CAS  PubMed  Google Scholar 

  32. Quemelo PR, Lourenco CM, Peres LC (2007) Teratogenic effect of retinoic acid in swiss mice. Acta Cir Bras 22:451–456

    PubMed  Google Scholar 

  33. Haustein KO (1999) Cigarette smoking, nicotine and pregnancy. Int J Clin Pharmacol Ther 37:417–427

    CAS  PubMed  Google Scholar 

  34. Haddow JE, Palomaki GE, Holman MS (1993) Young maternal age and smoking during pregnancy as risk factors for gastroschisis. Teratology 47:225–228

    CAS  PubMed  Google Scholar 

  35. Lam PK, Torfs CP (2006) Interaction between maternal smoking and malnutrition in infant risk of gastroschisis. Birth Defects Res A Clin Mol Teratol 76:182–186

    CAS  PubMed  Google Scholar 

  36. Torfs CP, Velie EM, Oechsli FW, Bateson TF, Curry CJ (1994) A population-based study of gastroschisis: demographic, pregnancy, and lifestyle risk factors. Teratology 50:44–53

    CAS  PubMed  Google Scholar 

  37. Yan J, Hales BF (2006) Depletion of glutathione induces 4-hydroxynonenal protein adducts and hydroxyurea teratogenicity in the organogenesis stage mouse embryo. J Pharmacol Exp Ther 319:613–621

    CAS  PubMed  Google Scholar 

  38. Mayura K, Reddy RV, Hayes AW, Berndt WO (1982) Embryocidal, fetotoxic and teratogenic effects of ochratoxin A in rats. Toxicology 25:175–185

    CAS  PubMed  Google Scholar 

  39. Patil RD, Dwivedi P, Sharma AK (2006) Critical period and minimum single oral dose of ochratoxin A for inducing developmental toxicity in pregnant Wistar rats. Reprod Toxicol 22:679–687

    CAS  PubMed  Google Scholar 

  40. Nomura T, Isa Y, Kurokawa N, Kanzaki T, Tanaka H, Tada E, Sakamoto Y (1984) Enhancement effects of barbital on the teratogenicity of aminopyrine. Toxicology 29:281–291

    CAS  PubMed  Google Scholar 

  41. Szabo KT, Guerriero FJ, Kang YJ (1978) The effects of gold-containing compounds on pregnant rats and their fetuses. Vet Pathol Suppl 15:89–96

    Google Scholar 

  42. Chaudhury MR, Chandrasekaran R, Mishra S (2001) Embryotoxicity and teratogenicity studies of an ayurvedic contraceptive—pippaliyadi vati. J Ethnopharmacol 74:189–193

    CAS  PubMed  Google Scholar 

  43. Hoffman DJ, Moore JM (1979) Teratogenic effects of external egg applications of methyl mercury in the mallard, Anas platyrhynchos. Teratology 20:453–461

    CAS  PubMed  Google Scholar 

  44. Barrow MV, Willis LS (1972) Ectopia cordis (ectocardia) and gastroschisis induced in rats by maternal administration of the lathyrogen, beta-aminopropionitrile (BAPN). Am Heart J 83:518–526

    CAS  PubMed  Google Scholar 

  45. Burdan F, Szumilo J, Dudka J, Korobowicz A, Klepacz R (2006) Celosomy is associated with prenatal exposure to cyclooxygenase inhibitors. Pharmacol Res 53:287–292

    CAS  PubMed  Google Scholar 

  46. Kasirsky G, Lombardi L (1970) Comparative teratogenic study of various corticoid ophthalmics. Toxicol Appl Pharmacol 16:773–778

    CAS  PubMed  Google Scholar 

  47. Thompson JM, Bannigan JG (2007) Omphalocele induction in the chick embryo by administration of cadmium. J Pediatr Surg 42:1703–1709

    PubMed  Google Scholar 

  48. Hales BF, Crosman K, Robaire B (1992) Increased postimplantation loss and malformations among the F2 progeny of male rats chronically treated with cyclophosphamide. Teratology 45:671–678

    CAS  PubMed  Google Scholar 

  49. Ognio E, Lapide M, Ottone M, Mandys V, Peterka M, Parodi B, Viale M (2003) Embryo-lethal and teratogenic effect of the new platinum compound DPR in pregnant mice. Arch Toxicol 77:584–590

    CAS  PubMed  Google Scholar 

  50. Wangikar PB, Dwivedi P, Sinha N (2004) Effect in rats of simultaneous prenatal exposure to ochratoxin A and aflatoxin B1. I. Maternal toxicity and fetal malformations. Birth Defects Res B Dev Reprod Toxicol 71:343–351

    CAS  PubMed  Google Scholar 

  51. Buttar HS, Dupuis I, Khera KS (1978) Dimethadione-induced fetotoxicity in rats. Toxicology 9:155–164

    CAS  PubMed  Google Scholar 

  52. Perez-D’Gregorio RE, Miller RK (1988) Teratogenicity of tellurium dioxide: prenatal assessment. Teratology 37:307–316

    PubMed  Google Scholar 

  53. Perez-D’Gregorio RE, Miller RK, Baggs RB (1988) Maternal toxicity and teratogenicity of tellurium dioxide in the Wistar rat: relationship to pair-feeding. Reprod Toxicol 2:55–61

    PubMed  Google Scholar 

  54. Ferm VH (1964) Teratogenic effects of hyperbaric oxygen. Proc Soc Exp Biol Med 116:975–976

    CAS  PubMed  Google Scholar 

  55. Parman T, Wiley MJ, Wells PG (1999) Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity. Nat Med 5:582–585

    CAS  PubMed  Google Scholar 

  56. Hung CF (1992) Experimentally induced axial dysraphism and anorectal malformation in male rat fetuses by intragastric administration of ethylenethiourea. J Formos Med Assoc 91:1166–1169

    CAS  PubMed  Google Scholar 

  57. Starkey DD, Nelson T, Shepard TH (1970) Teratogenicity of vitamin B6 deficiency: omphalocele, skeletal and neural defects, and splenic hypoplasia. Science 169:1329–1330

    Google Scholar 

  58. http://www.cdc.gov/nchs/icd9.htm

  59. Brewer S, Williams T (2004) Finally, a sense of closure? Animal models of human ventral body wall defects. Bioessays 26:1307–1321

    PubMed  Google Scholar 

  60. Brewer S, Williams T (2004) Loss of AP-2alpha impacts multiple aspects of ventral body wall development and closure. Dev Biol 267:399–417

    CAS  PubMed  Google Scholar 

  61. Drongowski RA, Smith RK Jr, Coran AG, Klein MD (1991) Contribution of demographic and environmental factors to the etiology of gastroschisis: a hypothesis. Fetal Diagn Ther 6:14–27

    CAS  PubMed  Google Scholar 

  62. Emusu D, Salihu HM, Aliyu ZY, Pierre-Louis BJ, Druschel CM, Kirby RS (2005) Gastroschisis, low maternal age, and fetal morbidity outcomes. Birth Defects Res A Clin Mol Teratol 73:649–654

    CAS  PubMed  Google Scholar 

  63. Werler MM, Mitchell AA, Shapiro S (1992) Demographic, reproductive, medical, and environmental factors in relation to gastroschisis. Teratology 45:353–360

    CAS  PubMed  Google Scholar 

  64. Draper ES, Rankin J, Tonks AM, Abrams KR, Field DJ, Clarke M, Kurinczuk JJ (2008) Recreational drug use: a major risk factor for gastroschisis? Am J Epidemiol 167:485–491

    PubMed  Google Scholar 

  65. Torfs CP, Katz EA, Bateson TF, Lam PK, Curry CJ (1996) Maternal medications and environmental exposures as risk factors for gastroschisis. Teratology 54:84–92

    CAS  PubMed  Google Scholar 

  66. Werler MM, Sheehan JE, Mitchell AA (2002) Maternal medication use and risks of gastroschisis and small intestinal atresia. Am J Epidemiol 155:26–31

    PubMed  Google Scholar 

  67. Werler MM, Mitchell AA, Shapiro S (1992) First trimester maternal medication use in relation to gastroschisis. Teratology 45:361–367

    CAS  PubMed  Google Scholar 

  68. Martinez-Frias ML, Rodriguez-Pinilla E, Prieto L (1997) Prenatal exposure to salicylates and gastroschisis: a case-control study. Teratology 56:241–243

    CAS  PubMed  Google Scholar 

  69. Lam PK, Torfs CP, Brand RJ (1999) A low pregnancy body mass index is a risk factor for an offspring with gastroschisis. Epidemiology 10:717–721

    CAS  PubMed  Google Scholar 

  70. Torfs CP, Lam PK, Schaffer DM, Brand RJ (1998) Association between mothers’ nutrient intake and their offspring’s risk of gastroschisis. Teratology 58:241–250

    CAS  PubMed  Google Scholar 

  71. Hoyme HE, Higginbottom MC, Jones KL (1981) The vascular pathogenesis of gastroschisis: intrauterine interruption of the omphalomesenteric artery. J Pediatr 98:228–231

    CAS  PubMed  Google Scholar 

  72. Hoyme HE, Jones MC, Jones KL (1983) Gastroschisis: abdominal wall disruption secondary to early gestational interruption of the omphalomesenteric artery. Semin Perinatol 7:294–298

    CAS  PubMed  Google Scholar 

  73. Thompson J, Bannigan J (2001) Effects of cadmium on formation of the ventral body wall in chick embryos and their prevention by zinc pretreatment. Teratology 64:87–97

    CAS  PubMed  Google Scholar 

  74. Thompson J, Hipwell E, Loo HV, Bannigan J (2005) Effects of cadmium on cell death and cell proliferation in chick embryos. Reprod Toxicol 20:539–548

    CAS  PubMed  Google Scholar 

  75. Moore M, Thor H, Moore G, Nelson S, Moldeus P, Orrenius S (1985) The toxicity of acetaminophen and N-acetyl-p-benzoquinone imine in isolated hepatocytes is associated with thiol depletion and increased cytosolic Ca2+. J Biol Chem 260:13035–13040

    CAS  PubMed  Google Scholar 

  76. Blaszkowska J (2002) Developmental abnormalities in chicken embryos after injection proteolysis inhibitors from Ascaris suum. Wiad Parazytol 48:55–64

    PubMed  Google Scholar 

  77. Zhang X, Schrott LM, Sparber SB (1998) Evidence for a serotonin-mediated effect of cocaine causing vasoconstriction and herniated umbilici in chicken embryos. Pharmacol Biochem Behav 59:585–593

    CAS  PubMed  Google Scholar 

  78. McBride WG, Vardy PH, French J (1982) Effects of scopolamine hydrobromide on the development of the chick and rabbit embryo. Aust J Biol Sci 35:173–178

    CAS  PubMed  Google Scholar 

  79. Guram MS, Gill TS, Geber WF (1982) Comparative teratogenicity of chlordiazepoxide, amitriptyline, and a combination of the two compounds in the fetal hamster. Neurotoxicology 3:83–90

    CAS  PubMed  Google Scholar 

  80. Wei X, Sulik KK (1993) Pathogenesis of craniofacial and body wall malformations induced by ochratoxin A in mice. Am J Med Genet 47:862–871

    CAS  PubMed  Google Scholar 

  81. Khera KS (1976) Teratogenicity studies with methotrexate, aminopterin, and acetylsalicylic acid in domestic cats. Teratology 14:21–27

    CAS  PubMed  Google Scholar 

  82. Khera KS, Iverson F (1978) Toxicity of ethylenethiourea in pregnant cats. Teratology 18:311–313

    CAS  PubMed  Google Scholar 

  83. Manner J, Seidl W, Heinicke F, Hesse H (2003) Teratogenic effects of suramin on the chick embryo. Anat Embryol (Berl) 206:229–237

    Google Scholar 

  84. Ferm VH (1969) The synteratogenic effect of lead and cadmium. Experientia 25:56–57

    CAS  PubMed  Google Scholar 

  85. Harris SB, Wilson JG, Printz RH (1972) Embryotoxicity of methyl mercuric chloride in golden hamsters. Teratology 6:139–142

    CAS  PubMed  Google Scholar 

  86. Casteel SW, Bailey EM, Camp BJ, Bridges CH, Hejtmancik E, Ueckert DN (1989) The developmental toxicity of an isolate from the plant Solanum dimidiatum (potato-weed) in Syrian golden hamsters. Toxicon 27:757–762

    CAS  PubMed  Google Scholar 

  87. Tellone CI, Baldwin JK, Sofia RD (1980) Teratogenic activity in the mouse after oral administration of acetazolamide. Drug Chem Toxicol 3:83–98

    CAS  PubMed  Google Scholar 

  88. Collins MD, Eckhoff C, Weiss R, Resnick E, Nau H, Scott WJ Jr (2006) Differential teratogenesis of all-trans-retinoic acid administered on gestational day 9.5 to SWV and C57BL/6N mice: emphasis on limb dysmorphology. Birth Defects Res A Clin Mol Teratol 76:96–106

    CAS  PubMed  Google Scholar 

  89. Takeno S, Sumita M, Saito H, Sakai T (1987) Strain differences in susceptibility to the embryotoxic effects of aminopyrine in mice. Res Commun Chem Pathol Pharmacol 57:409–419

    CAS  PubMed  Google Scholar 

  90. Yamamoto M, Takayama YI, Watanabe M, Ito S, Watanabe GI (1981) Immunological effects of antitestis antisera on the development of mouse fetuses. Teratology 24:53–63

    CAS  PubMed  Google Scholar 

  91. Barbieri O, Ognio E, Rossi O, Astigiano S, Rossi L (1986) Embryotoxicity of benzo(a)pyrene and some of its synthetic derivatives in Swiss mice. Cancer Res 46:94–98

    CAS  PubMed  Google Scholar 

  92. Hovland DN Jr, Machado AF, Scott WJ Jr, Collins MD (1999) Differential sensitivity of the SWV and C57BL/6 mouse strains to the teratogenic action of single administrations of cadmium given throughout the period of anterior neuropore closure. Teratology 60:13–21

    CAS  PubMed  Google Scholar 

  93. Shepard TH, Greenaway JC (1977) Teratogenicity of cytochalasin D in the mouse. Teratology 16:131–136

    CAS  PubMed  Google Scholar 

  94. Price CJ, Kimmel CA, George JD, Marr MC (1987) The developmental toxicity of diethylene glycol dimethyl ether in mice. Fundam Appl Toxicol 8:115–126

    CAS  PubMed  Google Scholar 

  95. Rogers JM, Carver B, Gray LE Jr, Gray JA, Kavlock RJ (1986) Teratogenic effects of the fungicide dinocap in the mouse. Teratog Carcinog Mutagen 6:375–381

    CAS  PubMed  Google Scholar 

  96. Nemirovsky MS (1970) The induction of congenital abnormalities in mice by means of heterologous anti-mouse placenta serum. Experientia 26:1138–1139

    CAS  PubMed  Google Scholar 

  97. Seller MJ, Perkins KJ (1983) Effect of hydroxyurea on neural tube defects in the curly-tail mouse. J Craniofac Genet Dev Biol 3:11–17

    CAS  PubMed  Google Scholar 

  98. Yusa T (1981) Chromosomal and teratogenic effects of oxygen in the mouse. Br J Anaesth 53:505–510

    CAS  PubMed  Google Scholar 

  99. Moallem SA, Niapour M (2008) Study of embryotoxicity of Perovskia abrotanoides, an adulterant in folk-medicine, during organogenesis in mice. J Ethnopharmacol 117:108–114

    PubMed  Google Scholar 

  100. Persaud TV, Henderson WM (1969) The teratogenicity of barbital sodium in mice. Arzneimittelforschung 19:1309–1310

    CAS  PubMed  Google Scholar 

  101. Blakley PM, Kim JS, Firneisz GD (1989) Effects of preconceptional and gestational exposure to Tordon 202c on fetal growth and development in CD-1 mice. Teratology 39:547–553

    CAS  PubMed  Google Scholar 

  102. Taubeneck MW, Daston GP, Rogers JM, Gershwin ME, Ansari A, Keen CL (1995) Tumor necrosis factor-alpha alters maternal and embryonic zinc metabolism and is developmentally toxic in mice. J Nutr 125:908–919

    CAS  PubMed  Google Scholar 

  103. Muller WU, Streffer C (1990) Lethal and teratogenic effects after exposure to X-rays at various times of early murine gestation. Teratology 42:643–650

    CAS  PubMed  Google Scholar 

  104. Hillebrandt S, Streffer C (2000) Relative biological effectiveness of neutrons: induction of malformations in a mouse strain with genetic predisposition. Radiat Res 153:595–598

    CAS  PubMed  Google Scholar 

  105. Baatout S, Jacquet P, Michaux A, Buset J, Vankerkom J, Derradji H, Yan J, von Suchodoletz H, de Saint-Georges L, Desaintes C, Mergeay M (2002) Developmental abnormalities induced by X-irradiation in p53 deficient mice. In Vivo 16:215–221

    CAS  PubMed  Google Scholar 

  106. Muller WU, Schotten H (1995) Induction of malformations by X-ray exposure of various stages of the oogenesis of mice. Mutat Res 331:119–125

    CAS  PubMed  Google Scholar 

  107. DeSesso JM (1979) Lectin teratogenesis: defects produced by concanavalin A in fetal rabbits. Teratology 19:15–25

    CAS  PubMed  Google Scholar 

  108. Cappon GD, Cook JC, Hurtt ME (2003) Relationship between cyclooxygenase 1 and 2 selective inhibitors and fetal development when administered to rats and rabbits during the sensitive periods for heart development and midline closure. Birth Defects Res B Dev Reprod Toxicol 68:47–56

    CAS  PubMed  Google Scholar 

  109. Kelich SL, Mercieca MD, Pohland RC (1995) Developmental toxicity of N-methylformamide administered by gavage to CD rats and New Zealand white rabbits. Fundam Appl Toxicol 27:239–246

    CAS  PubMed  Google Scholar 

  110. Rosen MB, House HS, Francis BM, Chernoff N (1990) Teratogenicity of 5-azacytidine in the Sprague–Dawley rat. J Toxicol Environ Health 29:201–210

    CAS  PubMed  Google Scholar 

  111. Kimmel CA, Wilson JG, Schumacher HJ (1971) Studies on metabolism and identification of the causative agent in aspirin teratogenesis in rats. Teratology 4:15–24

    PubMed  Google Scholar 

  112. Ong LL, Schardein JL, Petrere JA, Sakowski R, Jordan H, Humphrey RR, Fitzgerald JE, de la Iglesia FA (1983) Teratogenesis of calcium valproate in rats. Fundam Appl Toxicol 3:121–126

    CAS  PubMed  Google Scholar 

  113. Sitarek K (2001) Embryolethal and teratogenic effects of carbendazim in rats. Teratog Carcinog Mutagen 21:335–340

    CAS  PubMed  Google Scholar 

  114. Kai S, Kohmura H, Ishikawa K, Makihara Y, Ohta S, Kawano S, Takahashi N (1989) Teratogenic effects of carboplatin, an oncostatic drug, administered during the early organogenetic period in rats. J Toxicol Sci 14:115–130

    CAS  PubMed  Google Scholar 

  115. Slott VL, Hales BF (1986) Sodium 2-mercaptoethane sulfonate protection against cyclophosphamide-induced teratogenicity in rats. Toxicol Appl Pharmacol 82:80–86

    CAS  PubMed  Google Scholar 

  116. Mosier HD Jr, Dearden LC, Jansons RA, Roberts RC, Biggs CS (1982) Disproportionate growth of organs and body weight following glucocorticoid treatment of the rat fetus. Dev Pharmacol Ther 4:89–105

    CAS  PubMed  Google Scholar 

  117. Ema M, Itami T, Kawasaki H (1992) Susceptible period for the teratogenicity of di-n-butyltin dichloride in rats. Toxicology 73:81–92

    CAS  PubMed  Google Scholar 

  118. Neeper-Bradley TL, Tyl RW, Fisher LC, Kubena MF, Vrbanic MA, Losco PE (1995) Determination of a no-observed-effect level for developmental toxicity of ethylene glycol administered by gavage to CD rats and CD-1 mice. Fundam Appl Toxicol 27:121–130

    CAS  PubMed  Google Scholar 

  119. Yoshimura H (1987) Teratogenicity of flubendazole in rats. Toxicology 43:133–138

    CAS  PubMed  Google Scholar 

  120. Leung CC, Yan CL, Cheewatrakoolpong B (1990) Autologous immune complex glomerulonephritis induces abnormal embryonic development. J Reprod Immunol 17:141–154

    CAS  PubMed  Google Scholar 

  121. Hackett PL, Hess JO, Sikov MR (1982) Distribution and effects of intravenous lead in the fetoplacental unit of the rat. J Toxicol Environ Health 9:1021–1032

    Article  CAS  PubMed  Google Scholar 

  122. Minsker DH, MacDonald JS, Robertson RT, Bokelman DL (1983) Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase. Teratology 28:449–456

    CAS  PubMed  Google Scholar 

  123. Lane GA, Nahrwold ML, Tait AR, Taylor-Busch M, Cohen PJ, Beaudoin AR (1980) Anesthetics as teratogens: nitrous oxide is fetotoxic, xenon is not. Science 210:899–901

    CAS  PubMed  Google Scholar 

  124. Beaudoin AR (1982) Teratogenic action of platinum thymine blue. Life Sci 31:757–762

    CAS  PubMed  Google Scholar 

  125. Burdan F (2004) Developmental effects of propyphenazone in analgesic and antipyretic combination with caffeine or paracetamol. Hum Exp Toxicol 23:235–244

    CAS  PubMed  Google Scholar 

  126. Wise LD, Vetter CM, Anderson CA, Antonello JM, Clark RL (1991) Reversible effects of triamcinolone and lack of effects with aspirin or L-656, 224 on external genitalia of male Sprague–Dawley rats exposed in utero. Teratology 44:507–520

    CAS  PubMed  Google Scholar 

  127. Woodard JC (1970) Effects of deficiencies in labile methyl groups on the growth and development of fetal rats. J Nutr 100:1215–1225

    CAS  PubMed  Google Scholar 

  128. Woodard JC (1969) Study of one-carbon metabolism in neonatal vitamin B12-deficient rats. J Nutr 98:139–146

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Surgery, Wayne State University and Children’s Hospital of Michigan, Michigan, USA

    Dennis R. Van Dorp, John M. Malleis, Brian P. Sullivan & Michael D. Klein

Authors
  1. Dennis R. Van Dorp
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John M. Malleis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Brian P. Sullivan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael D. Klein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael D. Klein.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Van Dorp, D.R., Malleis, J.M., Sullivan, B.P. et al. Teratogens inducing congenital abdominal wall defects in animal models. Pediatr Surg Int 26, 127–139 (2010). https://doi.org/10.1007/s00383-009-2482-z

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00383-009-2482-z

Keywords

Search

Navigation